Clinical Trials Browser

Non-Squamous Non-Small Cell Lung Cancer × sintilimab × Clear all

NCT03802240 2023-11-27

Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure

Phase 3 Completed

Non-Squamous Non-Small Cell Lung Cancer